Every other day, scientists come up with a new technique to make the diagnosis of the disease more convenient. To what extent, this new technique will help scientists in accomplishing their mission?
FREMONT, CA: Currently, the pharma industry is witnessing drastic changes in its operations due to huge advancements in technology. Recently, a technique has been introduced, which levitates plasma proteins by using a magnetic field. The best part of the technique is that it provides precise information regarding the proteins’ density and can unveil signatures of disease, thus enabling clinicians to diagnose numerous conditions, like multiple sclerosis more conveniently.
In this technique, a sample of plasma protein is mixed with magnetic nanoparticles. Further, a magnetic field is created for separating distinct proteins into discernible bands. This allows scientists to define the proteins’ density in the solution accurately.
Plasma proteins have a significant role to play in normal physiological processes, as well as in disease. For example, antibodies are included in both immunity and auto-immune diseases. Similarly, lipoproteins are essential for transporting fats and also contribute considerably to cardiovascular disease. It is very vital to understand the fundamental properties of these kinds of proteins, which includes their density as well since it provides essential information about their contribution to the disease. However, at present, it has hard to measure the plasma protein density accurately.
The scientists and doctors believe that the plasma protein bands, which have been created via magnetic levitation, will be able to provide the signature of multiple diseases. The researchers, in the recently published study, made the comparison of the plasma of healthy volunteers with the people who abuse opioids. They found a different pattern in the plasma proteins of the opioid group, through which the individuals who abuse opioids had greater levels of specific types of hemoglobin.
Now, the researchers are marching towards trying to look for levitated protein signatures for diseases, like multiple sclerosis and cancer.